Shady Adnan Awad

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

Olli Dufva, Matti Kankainen, Tiina Kelkka et al. · Nature Communications · 2018 · 144 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia

Heikki Kuusanmäki, Olli Dufva, Markus Vähä‐Koskela et al. · Blood · 2022 · 125 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

Emma Andersson, S. Pützer, Bhagwan Yadav et al. · Leukemia · 2017 · 97 citations

Medicine, Molecular Biology, Oncology +15

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets

Shady Adnan Awad, Daehong Kim, Helena Hohtari et al. · Leukemia · 2020 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +17

Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia

Shady Adnan Awad, Matti Kankainen, Teija Ojala et al. · Blood Advances · 2020 · 68 citations · Full text

Life Sciences, Genetics, Oncology +17